EX-99.1 2 d503668dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

PRESS RELEASE

INVESTOR CONTACT:

Trey Campbell

Synopsys, Inc.

650-584-4289

Synopsys-ir@synopsys.com

EDITORIAL CONTACT:

Jim Brady

Synopsys, Inc.

408-482-4719

jim.brady@synopsys.com

Synopsys Posts Financial Results for Second Quarter Fiscal Year 2023

Q2 FY 2023 Financial Highlights

 

   

Revenue: $1.395 billion

 

   

GAAP earnings per diluted share: $1.76

 

   

Non-GAAP earnings per diluted share: $2.54

MOUNTAIN VIEW, Calif. May 17, 2023Synopsys, Inc. (Nasdaq: SNPS) today reported results for its second quarter of fiscal year 2023. Revenue for the second quarter of fiscal year 2023 was $1.395 billion, compared to $1.279 billion for the second quarter of fiscal year 2022.

“Synopsys generated excellent financial results and operational execution in the second quarter. We exceeded all our guidance targets, while reaching another quarterly revenue record,” said Aart de Geus, Chair and CEO of Synopsys. “Our financial performance is the product of a relentless drive for technology innovation and years of building trust in our customer base. Our industry-leading AI-driven design platform, Synopsys.ai, unleashes our next wave of impact as our customers drive a groundswell of ‘smart, secure, and safe’ new products.”

“Exceptional execution across the company drove strong quarterly financial performance,” said Shelagh Glaser, CFO of Synopsys. “We have a resilient business model uncommon in software companies and remain confident in our business. We are raising our full year guidance and expect revenue growth of 14-15%, non-GAAP operating margin accretion of 150 basis points to 34.5%, and non-GAAP earnings per share growth of 21-22%.”

 

1


GAAP Results

On a generally accepted accounting principles (GAAP) basis, net income for the second quarter of fiscal year 2023 was $272.9 million, or $1.76 per diluted share, compared to $294.8 million, or $1.89 per diluted share, for the second quarter of fiscal year 2022.

Non-GAAP Results

On a non-GAAP basis, net income for the second quarter of fiscal year 2023 was $393.3 million, or $2.54 per diluted share, compared to non-GAAP net income of $390.8 million, or $2.50 per diluted share, for the second quarter of fiscal year 2022.

For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see “GAAP to Non-GAAP Reconciliation” in the accompanying tables below.

Business Segments

Synopsys reports revenue and operating income in three segments: (1) Design Automation, which includes digital and custom integrated circuit (IC) design software, verification hardware and software products, manufacturing-related design products, field-programmable gate array (FPGA) design software, optical products, professional services, and other; (2) Design IP, which includes our Synopsys IP portfolio; and (3) Software Integrity, which includes solutions that test software code for security vulnerabilities and quality defects, as well as professional and managed services. Further information regarding these segments is provided at the end of this press release.

Financial Targets

Synopsys also provided its consolidated financial targets for the third quarter and full fiscal year 2023. These financial targets assume no further changes to export control restrictions or the current U.S. government “Entity List” restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see “Forward-Looking Statements” below.

 

2


Third Quarter and Fiscal Year 2023 Financial Targets (1)

(in millions except per share amounts)

 

     Range for Three Months Ending     Range for Fiscal Year Ending  
     July 31, 2023     October 31, 2023  
     Low     High     Low     High  

Revenue

   $ 1,465     $ 1,495     $ 5,790     $ 5,830  

GAAP Expenses

   $ 1,143     $ 1,163     $ 4,520     $ 4,565  

Non-GAAP Expenses

   $ 970     $ 980     $ 3,790     $ 3,820  

Non-GAAP Other Income (Expense)

   $ —       $ 2     $ 4     $ 8  

Non-GAAP Tax Rate

     16     16     16     16

Outstanding Shares (fully diluted)

     155       158       155       158  

GAAP EPS

   $ 1.88     $ 1.99     $ 7.44     $ 7.60  

Non-GAAP EPS

   $ 2.70     $ 2.75     $ 10.77     $ 10.84  

Operating Cash Flow

         ~ $1,650  

 

(1)

Synopsys’ third quarter of fiscal year 2023 and fiscal year 2023 will end on July 29, 2023 and October 28, 2023, respectively. For presentation purposes, we refer to the closest calendar month end.

For a reconciliation of Synopsys’ third quarter and fiscal year 2023 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see “GAAP to Non-GAAP Reconciliation” in the accompanying tables below.

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys’ corporate website at www.synopsys.com. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the third quarter in August 2023. Synopsys will post copies of the prepared remarks on its website following today’s call. In addition, Synopsys makes additional information available in a financial supplement and corporate overview presentation, also posted on the corporate website.

Effectiveness of Information

The targets included in this press release, the statements made during the earnings conference call and the information contained in the financial supplement and the corporate overview presentation (available on Synopsys’ corporate website at www.synopsys.com) represent Synopsys’ expectations and beliefs as of May 17, 2023. Although this press release, copies of the prepared remarks made during the earnings conference call, the financial supplement, and the corporate overview presentation will remain available on Synopsys’ website through the date of the earnings call for the third quarter fiscal year 2023, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

 

3


Availability of Final Financial Statements

Synopsys will include final financial statements for the second quarter of fiscal year 2023 in its quarterly report on Form 10-Q to be filed on or before June 8, 2023.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry’s broadest portfolio of application security testing tools and services. Whether you’re a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at www.synopsys.com.

GAAP to Non-GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP, but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys’ operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal planning and forecasting purposes. These non-GAAP measures may be different from non-GAAP measures used by other companies. Synopsys’ management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys’ management believes it is useful for itself and investors to review, as applicable, both GAAP financial measures that include: (i) the amortization of acquired intangible assets, (ii) the impact of stock compensation, (iii) acquisition-related items, (iv) restructuring charges, (v) the effects of certain settlements, final judgments and loss contingencies related to legal proceedings, and (vi) the income tax effect of non-GAAP pre-tax adjustments; and the non-GAAP financial measures that exclude such information in order to assess the performance of Synopsys’ business operations and for planning and forecasting in subsequent periods.

 

4


Synopsys utilizes an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect Synopsys’ normal operations, and to more closely align its tax rate with its expected geographic earnings mix. This annual non-GAAP tax rate was based on an evaluation of Synopsys’ historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives.

Synopsys previously elected to maintain an annual non-GAAP tax rate of 18% for fiscal year 2023 given uncertainty surrounding further U.S. corporate tax law changes. Based on a re-evaluation of federal tax laws that require research and development expense to be capitalized commencing in Synopsys’ first quarter of fiscal year 2023, Synopsys elected to update its annual non-GAAP tax rate for fiscal year 2023 to 16% on February 17, 2023. Synopsys does not currently anticipate any additional significant changes to U.S. corporate tax law, its geographic earnings mix, or significant tax law changes in major jurisdictions where it operates that would result in further adjustment to its fiscal year 2023 annual non-GAAP tax rate.

When possible, Synopsys provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below, as well as Item 2.02 of Synopsys’ Current Report on Form 8-K filed on May 17, 2023, for additional information about the measures Synopsys uses to evaluate its core business operations. Synopsys is unable to provide a reconciliation of certain non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis because doing so would not be possible without unreasonable effort due to, among other things, the potential variability and limited visibility of the excluded items. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information.

 

5


Reconciliation of Second Quarter Fiscal Year 2023 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per diluted share for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Second Quarter Fiscal Year 2023 Results(1)

(unaudited and in thousands, except per share amounts)

 

     Three Months Ended
April 30,
     Six Months Ended
April 30,
 
     2023      2022      2023      2022  

GAAP net income attributed to Synopsys

   $ 272,910      $ 294,781      $ 544,446      $ 608,468  

Adjustments:

           

Amortization of intangible assets

     23,449        21,367        47,827        43,727  

Stock compensation

     143,012        110,061        276,879        205,832  

Acquisition-related items

     2,711        4,023        5,306        6,100  

Restructuring charges

     4,140        311        44,999        12,057  

Tax adjustments

     (52,947      (39,703      (119,512      (108,456
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income attributed to Synopsys

   $ 393,275      $ 390,840      $ 799,945      $ 767,728  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three Months Ended
April 30,
     Six Months Ended
April 30,
 
     2023      2022      2023      2022  

GAAP net income per diluted share attributed to Synopsys

   $ 1.76      $ 1.89      $ 3.51      $ 3.88  

Adjustments:

           

Amortization of intangible assets

     0.15        0.14        0.31        0.28  

Stock compensation

     0.92        0.70        1.79        1.31  

Acquisition-related items

     0.02        0.03        0.03        0.04  

Restructuring charges

     0.03        —          0.29        0.08  

Tax adjustments

     (0.34      (0.26      (0.77      (0.69
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income per diluted share attributed to Synopsys

   $ 2.54      $ 2.50      $ 5.16      $ 4.90  
  

 

 

    

 

 

    

 

 

    

 

 

 

Shares used in computing net income per diluted share amounts:

     154,730        156,167        155,044        156,815  

 

(1)

Synopsys’ second quarter of fiscal year 2023 and 2022 ended on April 29, 2023 and April 30, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

 

6


Reconciliation of 2023 Targets

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Third Quarter Fiscal Year 2023 Targets (1)

(in thousands, except per share amounts)

 

     Range for Three Months Ending
July 31, 2023
 
     Low      High  

Target GAAP expenses

   $ 1,143,000      $ 1,163,000  

Adjustments:

     

Amortization of intangible assets

     (25,000      (28,000

Stock compensation

     (148,000      (155,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 970,000      $ 980,000  
  

 

 

    

 

 

 

 

     Range for Three Months Ending
July 31, 2023
 
     Low      High  

Target GAAP earnings per diluted share attributed to Synopsys

   $ 1.88      $ 1.99  

Adjustments:

     

Amortization of intangible assets

     0.18        0.16  

Stock compensation

     0.99        0.95  

Tax adjustments

     (0.35      (0.35
  

 

 

    

 

 

 

Target non-GAAP earnings per diluted share attributed to Synopsys

   $ 2.70      $ 2.75  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     156,500        156,500  

GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2023 Targets (1)

(in thousands, except per share amounts)

 

     Range for Fiscal Year Ending
October 31, 2023
 
     Low      High  

Target GAAP expenses

   $ 4,520,305      $ 4,565,305  

Adjustments:

     

Amortization of intangible assets

     (100,000      (105,000

Stock compensation

     (580,000      (590,000

Acquisition-related items

     (5,306      (5,306

Restructuring charges

     (44,999      (44,999
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 3,790,000      $ 3,820,000  
  

 

 

    

 

 

 

 

7


     Range for Fiscal Year Ending  
     October 31, 2023  
     Low      High  

Target GAAP earnings per diluted share attributed to Synopsys

   $ 7.44      $ 7.60  

Adjustments:

     

Amortization of intangible assets

     0.67        0.64  

Stock compensation

     3.77        3.71  

Acquisition-related items

     0.03        0.03  

Restructuring charges

     0.29        0.29  

Tax adjustments

     (1.43      (1.43
  

 

 

    

 

 

 

Target non-GAAP earnings per diluted share attributed to Synopsys

   $ 10.77      $ 10.84  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     156,500        156,500  

 

(1)

Synopsys’ third quarter of fiscal year 2023 and fiscal year 2023 will end on July 29, 2023 and October 28, 2023, respectively. For presentation purposes, we refer to the closest calendar month end.

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements regarding Synopsys’ short-term and long-term financial targets, expectations and objectives; strategies related to our products, technology and services; business and market outlook, opportunities and strategies; the expected impact of U.S. and foreign government actions and regulatory changes, including export control restrictions on our financial results; the potential impact of the uncertain macroeconomic environment on our financial results; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; software trends; planned acquisitions and stock repurchases; our expected tax rate; and the impact and result of pending legal, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations;

 

8


and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys’ results is included in filings we make with the SEC from time to time, including in the sections entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended October 31, 2022 and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys’ most recent reports on Forms 10-K and 10-Q each as may be amended from time to time. Synopsys’ financial results for its second quarter fiscal year 2023 are not necessarily indicative of Synopsys’ operating results for any future periods. The information provided herein is as of May 17, 2023. Synopsys undertakes no duty, and does not intend, to update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

 

9


SYNOPSYS, INC.

Unaudited Condensed Consolidated Statements of Income(1)

(in thousands, except per share amounts)

 

     Three Months Ended     Six Months Ended  
     April 30,     April 30,  
     2023     2022     2023     2022  

Revenue:

        

Time-based products

   $ 808,196     $ 723,821     $ 1,590,509     $ 1,431,304  

Upfront products

     345,524       336,625       682,182       704,899  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total products revenue

     1,153,720       1,060,446       2,272,691       2,136,203  

Maintenance and service

     241,143       218,783       483,512       413,281  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     1,394,863       1,279,229       2,756,203       2,549,484  

Cost of revenue:

        

Products

     184,732       150,690       359,099       316,089  

Maintenance and service

     95,410       87,666       186,757       165,891  

Amortization of intangible assets

     17,872       14,455       36,512       27,815  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenue

     298,014       252,811       582,368       509,795  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     1,096,849       1,026,418       2,173,835       2,039,689  

Operating expenses:

        

Research and development

     485,597       389,964       950,926       773,935  

Sales and marketing

     222,115       191,573       432,900       372,083  

General and administrative

     91,083       73,957       188,447       154,965  

Amortization of intangible assets

     6,582       6,912       13,299       15,912  

Restructuring charges

     4,140       311       44,999       12,057  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     809,517       662,717       1,630,571       1,328,952  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     287,332       363,701       543,264       710,737  

Other income (expense), net

     4,253       (23,913     27,545       (43,706
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     291,585       339,788       570,809       667,031  

Provision (benefit) for income taxes

     21,637       45,896       32,234       59,798  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     269,948       293,892       538,575       607,233  

Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest

     (2,962     (889     (5,871     (1,235
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributed to Synopsys

   $ 272,910     $ 294,781     $ 544,446     $ 608,468  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share attributed to Synopsys:

        

Basic

   $ 1.79     $ 1.93     $ 3.57     $ 3.97  

Diluted

   $ 1.76     $ 1.89     $ 3.51     $ 3.88  

Shares used in computing per share amounts:

        

Basic

     152,187       153,090       152,294       153,154  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     154,730       156,167       155,044       156,815  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Synopsys’ second quarter of fiscal year 2023 and 2022 ended on April 29, 2023 and April 30, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

 

10


SYNOPSYS, INC.

Unaudited Condensed Consolidated Balance Sheets (1)

(in thousands, except par value amounts)

 

     April 30, 2023     October 31, 2022  

ASSETS:

    

Current assets:

    

Cash and cash equivalents

   $ 1,544,592     $ 1,417,608  

Short-term investments

     150,846       147,913  
  

 

 

   

 

 

 

Total cash, cash equivalents & short-term investments

     1,695,438       1,565,521  

Accounts receivable, net

     779,892       796,091  

Inventories

     256,426       211,927  

Prepaid and other current assets

     429,179       439,130  
  

 

 

   

 

 

 

Total current assets

     3,160,935       3,012,669  

Property and equipment, net

     546,439       483,300  

Operating lease right-of-use assets, net

     576,727       559,090  

Goodwill

     3,888,249       3,842,234  

Intangible assets, net

     357,113       386,446  

Deferred income taxes

     774,391       670,653  

Other long-term assets

     486,878       463,695  
  

 

 

   

 

 

 

Total assets

   $ 9,790,732     $ 9,418,087  
  

 

 

   

 

 

 

LIABILITIES, REDEEMABLE NON-CONTROLLING
INTEREST AND STOCKHOLDERS’ EQUITY:

    

Current liabilities:

    

Accounts payable and accrued liabilities

   $ 701,816     $ 809,403  

Operating lease liabilities

     78,056       54,274  

Deferred revenue

     1,968,808       1,910,822  
  

 

 

   

 

 

 

Total current liabilities

     2,748,680       2,774,499  

Long-term operating lease liabilities

     591,667       581,273  

Long-term deferred revenue

     191,413       154,472  

Long-term debt

     20,201       20,824  

Other long-term liabilities

     365,949       327,829  
  

 

 

   

 

 

 

Total liabilities

     3,917,910       3,858,897  

Redeemable non-controlling interest

     35,877       38,664  

Stockholders’ equity:

    

Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

     —         —    

Common stock, $0.01 par value: 400,000 shares authorized; 152,251 and 152,375 shares outstanding, respectively

     1,523       1,524  

Capital in excess of par value

     1,330,072       1,487,126  

Retained earnings

     6,075,009       5,534,307  

Treasury stock, at cost: 5,010 and 4,886 shares, respectively

     (1,428,748     (1,272,955

Accumulated other comprehensive income (loss)

     (145,997     (234,277
  

 

 

   

 

 

 

Total Synopsys stockholders’ equity

     5,831,859       5,515,725  

Non-controlling interest

     5,086       4,801  
  

 

 

   

 

 

 

Total stockholders’ equity

     5,836,945       5,520,526  
  

 

 

   

 

 

 

Total liabilities, redeemable non-controlling interest and stockholders’ equity

   $ 9,790,732     $ 9,418,087  
  

 

 

   

 

 

 

 

(1)

Synopsys’ second quarter of fiscal year 2023 ended April 29, 2023 and its fiscal year 2022 ended on October 29, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

 

11


SYNOPSYS, INC.

Unaudited Condensed Consolidated Statements of Cash Flows (1)

(in thousands)

 

     Six Months Ended April 30,  
     2023     2022  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net income

   $ 538,575     $ 607,233  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Amortization and depreciation

     116,922       111,962  

Reduction of operating lease right-of-use assets

     48,073       42,412  

Amortization of capitalized costs to obtain revenue contracts

     39,588       34,574  

Stock-based compensation

     277,485       205,832  

Allowance for credit losses

     6,134       (4,516

Deferred income taxes

     (125,090     8,944  

Other non-cash

     4,972       7,479  

Net changes in operating assets and liabilities, net of acquired assets and liabilities:

    

Accounts receivable

     9,289       (169,785

Inventories

     (48,648     7,725  

Prepaid and other current assets

     49,437       (2,417

Other long-term assets

     (75,324     (8,701

Accounts payable and accrued liabilities

     (162,840     (181,008

Operating lease liabilities

     (31,634     (43,963

Income taxes

     94,587       (34,246

Deferred revenue

     76,165       324,176  
  

 

 

   

 

 

 

Net cash provided by operating activities

     817,691       905,701  

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Proceeds from sales and maturities of short-term investments

     67,717       43,653  

Purchases of short-term investments

     (68,738     (45,158

Proceeds from sales of long-term investments

     7,248       582  

Purchases of long-term investments

     —         (7,000

Purchases of property and equipment

     (91,368     (67,367

Acquisitions, net of cash acquired

     (41,324     (109,060

Capitalization of software development costs

     (1,247     (1,065

Other

     —         (600
  

 

 

   

 

 

 

Net cash used in investing activities

     (127,712     (186,015

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Repayment of debt

     (1,294     (75,938

Issuances of common stock

     132,808       120,710  

Payments for taxes related to net share settlement of equity awards

     (116,838     (101,126

Purchase of equity forward contract

     (45,000     —    

Purchases of treasury stock

     (560,724     (500,000

Other

     (122     (2,709
  

 

 

   

 

 

 

Net cash used in financing activities

     (591,170     (559,063

Effect of exchange rate changes on cash, cash equivalents and restricted cash

     27,708       (19,955
  

 

 

   

 

 

 

Net change in cash, cash equivalents and restricted cash

     126,517       140,668  

Cash, cash equivalents and restricted cash, beginning of year

     1,419,864       1,435,183  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period

   $  1,546,381     $  1,575,851  
  

 

 

   

 

 

 

 

(1)

Synopsys’ second quarter of fiscal year 2023 and 2022 ended on April 29, 2023 and April 30, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

 

12


SYNOPSYS, INC.

Business Segment Reporting (1)(3)

(in millions)

 

     Three Months
Ended
April 30, 2023
    Three Months
Ended
April 30, 2022
    Six Months
Ended
April 30, 2023
    Six Months
Ended
April, 2022
 

Revenue by segment

        

- Design Automation

   $ 927.6     $ 817.8     $  1,817.4     $  1,621.7  

% of Total

     66.5     64.0     66.0     63.7

- Design IP

   $ 335.2     $ 348.5     $ 678.8     $ 707.4  

% of Total

     24.0     27.2     24.6     27.7

- Software Integrity

   $ 132.1     $ 112.9     $ 260.0     $ 220.4  

% of Total

     9.5     8.8     9.4     8.6

Total segment revenue

   $ 1,394.9     $ 1,279.2     $ 2,756.2     $ 2,549.5  

Adjusted operating income by segment

        

- Design Automation

   $ 360.1     $ 321.4     $ 706.1     $ 614.7  

- Design IP

   $ 86.3     $ 135.7     $ 203.9     $ 289.9  

- Software Integrity

   $ 18.3     $ 13.0     $ 33.8     $ 25.0  

Total adjusted segment operating income

   $ 464.7     $ 470.2     $ 943.9     $ 929.5  

Adjusted operating margin by segment

        

- Design Automation

     38.8     39.3     38.9     37.9

- Design IP

     25.8     38.9     30.0     41.0

- Software Integrity

     13.9     11.5     13.0     11.4

Total adjusted segment operating margin

     33.3     36.8     34.2     36.5

 

13


Total Adjusted Segment Operating Income Reconciliation (1)(2)(3)

(in millions)

 

     Three Months
Ended
April 30, 2023
     Three Months
Ended
April 30, 2022
    Six Months
Ended
April 30, 2023
     Six Months
Ended
April 30, 2022
 

GAAP total operating income – as reported

   $ 287.3      $ 363.7     $ 543.3      $ 710.7  

Other expenses managed at consolidated level

          

-Amortization of intangible assets (4)

     24.5        21.4       49.8        43.7  

-Stock compensation (4)

     143.3        110.1       277.5        205.8  

-Non-qualified deferred compensation plan

     2.8        (29.3     23.0        (48.9

-Acquisition-related items

     2.7        4.0       5.3        6.1  

-Restructuring charges

     4.1        0.3       45.0        12.1  
  

 

 

    

 

 

   

 

 

    

 

 

 

Total adjusted segment operating income

   $ 464.7      $ 470.2     $ 943.9      $ 929.5  
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1)

Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our business. Amounts may not foot due to rounding.

(2)

These segments results are consistent with the information required by ASC 280, Segment Reporting. Synopsys’ chief operating decision maker (CODM) is our Chief Executive Officer. The CODM does not allocate certain operating expenses managed at a consolidated level to our reportable segments and, as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table above.

(3)

Synopsys’ second quarter of fiscal year 2023 and 2022 ended on April 29, 2023 and April 30, 2022, respectively. For presentation purposes, we refer to the closest calendar month end.

(4)

The adjustment includes non-GAAP expenses attributable to non-controlling interest and redeemable non-controlling interest.

 

14